JPWO2020250915A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020250915A5 JPWO2020250915A5 JP2021526105A JP2021526105A JPWO2020250915A5 JP WO2020250915 A5 JPWO2020250915 A5 JP WO2020250915A5 JP 2021526105 A JP2021526105 A JP 2021526105A JP 2021526105 A JP2021526105 A JP 2021526105A JP WO2020250915 A5 JPWO2020250915 A5 JP WO2020250915A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- days
- administration
- composition according
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022085724A JP2022116185A (ja) | 2019-06-10 | 2022-05-26 | サイトカイン阻害剤と組み合わせて使用するための抗ｔ細胞抗原結合分子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019107894 | 2019-06-10 | ||
| JP2019107894 | 2019-06-10 | ||
| JP2019124364 | 2019-07-03 | ||
| JP2019124364 | 2019-07-03 | ||
| PCT/JP2020/022771 WO2020250915A1 (ja) | 2019-06-10 | 2020-06-10 | サイトカイン阻害剤と組み合わせて使用するための抗ｔ細胞抗原結合分子 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022085724A Division JP2022116185A (ja) | 2019-06-10 | 2022-05-26 | サイトカイン阻害剤と組み合わせて使用するための抗ｔ細胞抗原結合分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020250915A1 JPWO2020250915A1 (https=) | 2020-12-17 |
| JPWO2020250915A5 true JPWO2020250915A5 (https=) | 2022-04-06 |
| JP7082245B2 JP7082245B2 (ja) | 2022-06-07 |
Family
ID=73780894
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526105A Expired - Fee Related JP7082245B2 (ja) | 2019-06-10 | 2020-06-10 | サイトカイン阻害剤と組み合わせて使用するための抗ｔ細胞抗原結合分子 |
| JP2022085724A Pending JP2022116185A (ja) | 2019-06-10 | 2022-05-26 | サイトカイン阻害剤と組み合わせて使用するための抗ｔ細胞抗原結合分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022085724A Pending JP2022116185A (ja) | 2019-06-10 | 2022-05-26 | サイトカイン阻害剤と組み合わせて使用するための抗ｔ細胞抗原結合分子 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220348658A1 (https=) |
| EP (1) | EP3981429A4 (https=) |
| JP (2) | JP7082245B2 (https=) |
| KR (2) | KR102486064B1 (https=) |
| CN (1) | CN114126649A (https=) |
| AU (1) | AU2020291300A1 (https=) |
| CA (1) | CA3140537A1 (https=) |
| CR (1) | CR20220008A (https=) |
| IL (1) | IL288374A (https=) |
| MA (1) | MA56131A (https=) |
| MX (1) | MX2021015007A (https=) |
| TW (1) | TWI868154B (https=) |
| WO (1) | WO2020250915A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3434767T (pt) | 2010-11-30 | 2026-01-23 | Chugai Pharmaceutical Co Ltd | Agente terapêutico indutor de citotoxicidade |
| TW202200615A (zh) * | 2020-03-12 | 2022-01-01 | 美商安進公司 | 用於治療和預防患者的crs之方法 |
| CA3214628A1 (en) * | 2021-04-06 | 2022-10-13 | Memorial Sloan-Kettering Cancer Center | Combination therapy with dexamethasone and tumor-specific t cell engaging multi-specific antibodies for treating cancer |
| WO2024083959A1 (en) * | 2022-10-20 | 2024-04-25 | Monta Biosciences Aps | Pre-medication and improved treatment regimen |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773719A (en) | 1966-12-06 | 1973-11-20 | Hoffmann La Roche | 2-aminoxy-2'-acyl-acetanilide |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| ATE375365T1 (de) | 1998-04-02 | 2007-10-15 | Genentech Inc | Antikörper varianten und fragmente davon |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| PL209392B1 (pl) | 1999-01-15 | 2011-08-31 | Genentech Inc | Przeciwciało, komórka gospodarza, sposób wytwarzania przeciwciała oraz zastosowanie przeciwciała |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| JP2003531588A (ja) | 2000-04-11 | 2003-10-28 | ジェネンテック・インコーポレーテッド | 多価抗体とその用途 |
| US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| TWI335821B (en) | 2002-12-16 | 2011-01-11 | Genentech Inc | Immunoglobulin variants and uses thereof |
| WO2008027236A2 (en) | 2006-08-30 | 2008-03-06 | Genentech, Inc. | Multispecific antibodies |
| EP2144931A2 (en) | 2007-04-04 | 2010-01-20 | The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services | Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| JP6157046B2 (ja) | 2008-01-07 | 2017-07-05 | アムジェン インコーポレイテッド | 静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法 |
| PT3434767T (pt) | 2010-11-30 | 2026-01-23 | Chugai Pharmaceutical Co Ltd | Agente terapêutico indutor de citotoxicidade |
| AU2015244814B2 (en) | 2014-04-07 | 2020-12-24 | Chugai Seiyaku Kabushiki Kaisha | Immunoactivating antigen-binding molecule |
| MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
| CN107556387A (zh) * | 2016-06-30 | 2018-01-09 | 中国科学院深圳先进技术研究院 | 抗gpc3和cd3特异性双靶向抗体、含该双靶向抗体表达盒的微环dna及应用 |
| JP7784795B2 (ja) * | 2016-11-15 | 2025-12-12 | ジェネンテック， インコーポレイテッド | 抗ｃｄ２０／抗ｃｄ３二重特異性抗体による処置のための投与 |
-
2020
- 2020-06-10 WO PCT/JP2020/022771 patent/WO2020250915A1/ja not_active Ceased
- 2020-06-10 CA CA3140537A patent/CA3140537A1/en active Pending
- 2020-06-10 MA MA056131A patent/MA56131A/fr unknown
- 2020-06-10 KR KR1020217041104A patent/KR102486064B1/ko active Active
- 2020-06-10 CN CN202080051046.XA patent/CN114126649A/zh active Pending
- 2020-06-10 CR CR20220008A patent/CR20220008A/es unknown
- 2020-06-10 KR KR1020237000158A patent/KR20230011470A/ko active Pending
- 2020-06-10 JP JP2021526105A patent/JP7082245B2/ja not_active Expired - Fee Related
- 2020-06-10 TW TW109119459A patent/TWI868154B/zh active
- 2020-06-10 US US17/616,373 patent/US20220348658A1/en not_active Abandoned
- 2020-06-10 AU AU2020291300A patent/AU2020291300A1/en not_active Abandoned
- 2020-06-10 EP EP20822960.9A patent/EP3981429A4/en not_active Withdrawn
- 2020-06-10 MX MX2021015007A patent/MX2021015007A/es unknown
-
2021
- 2021-11-24 IL IL288374A patent/IL288374A/en unknown
-
2022
- 2022-05-26 JP JP2022085724A patent/JP2022116185A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020250915A5 (https=) | ||
| JP2024156736A5 (https=) | ||
| JP2023002544A5 (https=) | ||
| JP2021517566A5 (https=) | ||
| CN114641293A (zh) | 一种fgfr抑制剂的用途 | |
| JP2024518947A5 (https=) | ||
| JP2019517549A5 (https=) | ||
| JP2017511793A5 (https=) | ||
| JP2023501375A5 (https=) | ||
| IL300151A (en) | Combinations for cancer treatment | |
| Conn | The story behind the use of glucocorticoids in the treatment of rheumatoid arthritis | |
| JP2020516646A5 (https=) | ||
| JP2015525798A5 (https=) | ||
| JP2024527109A5 (https=) | ||
| JP2023517535A5 (https=) | ||
| IL320562A (en) | Cancer treatment methods | |
| JP2024517085A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| JP2023505687A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2025509278A5 (https=) | ||
| JP2022549066A5 (https=) | ||
| JP2023109829A5 (https=) | ||
| JP2022513029A5 (https=) | ||
| JP2024512558A5 (https=) |